Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

Three phase II randomized trials evaluated the safety/immunogenicity of two formulations of live-attenuated tetravalent dengue virus (TDEN) vaccine in dengue-endemic (Puerto Rico, Thailand) and non-endemic (US) regions (NCT00350337/NCT00370682/NCT00468858). We describe cell-mediated immune (CMI) res...

Descripción completa

Detalles Bibliográficos
Autores principales: Moris, Philippe, Bauer, Kristen M., Currier, Jeffrey R., Friberg, Heather, Eckels, Kenneth H., Esquilin, Ines O., Gibbons, Robert V., Innis, Bruce L., Jarman, Richard G., Simasathien, Sriluck, Sun, Peifang, Thomas, Stephen J., Watanaveeradej, Veerachai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773406/
https://www.ncbi.nlm.nih.gov/pubmed/30829100
http://dx.doi.org/10.1080/21645515.2019.1581536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773406/
https://www.ncbi.nlm.nih.gov/pubmed/30829100
http://dx.doi.org/10.1080/21645515.2019.1581536

Ejemplares similares